MALDI-Based Method May Reduce Cost of Rx-Screening Assays, Speed Drug Development
October 09, 2009
MALDI-Based Method May Reduce Cost of Rx-Screening Assays, Speed Drug Development
The technique is based on a MALDI triple-quadrupole platform and exploits the selective multiple-reaction monitoring transition features of the instrument to circumvent problems resulting from interference that can plague existing methods.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.